iTeos Therapeutics, Inc. (ITOS) DCF Valuation

iTeos Therapeutics, Inc. (ITOS) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

iTeos Therapeutics, Inc. (ITOS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate iTeos Therapeutics, Inc.'s (ITOS) financial outlook like an expert! This (ITOS) DCF Calculator provides you with pre-filled financial data and full flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your predictions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 344.8 267.6 12.6 8.9 6.3 4.4 3.1 2.2
Revenue Growth, % 0 0 0 -22.38 -95.29 -29.42 -29.42 -29.42 -29.42 -29.42
EBITDA -21.7 -37.8 257.1 148.4 -151.1 4.1 2.9 2.0 1.4 1.0
EBITDA, % 100 100 74.56 55.44 -1199.69 46 46 46 46 46
Depreciation .6 .5 .6 .8 .9 3.7 2.6 1.8 1.3 .9
Depreciation, % 100 100 0.17838 0.30378 7.13 41.52 41.52 41.52 41.52 41.52
EBIT -22.3 -38.4 256.5 147.6 -152.0 4.1 2.9 2.0 1.4 1.0
EBIT, % 100 100 74.39 55.14 -1206.82 45.9 45.9 45.9 45.9 45.9
Total Cash 19.9 336.3 848.5 613.2 531.9 8.9 6.3 4.4 3.1 2.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 5.3 .3 12.1 2.4 6.5
Account Receivables, % 100 100 3.51 0.90984 51.61
Inventories .0 -.3 -10.1 .0 .0 3.5 2.5 1.7 1.2 .9
Inventories, % 100 100 -2.93 0 0 39.41 39.41 39.41 39.41 39.41
Accounts Payable 1.2 3.0 5.1 7.7 11.3 5.2 3.7 2.6 1.8 1.3
Accounts Payable, % 100 100 1.49 2.86 89.66 58.8 58.8 58.8 58.8 58.8
Capital Expenditure -.7 -.4 -1.2 -.9 -3.0 -.4 -.3 -.2 -.2 -.1
Capital Expenditure, % 100 100 -0.34254 -0.35048 -23.55 -4.85 -4.85 -4.85 -4.85 -4.85
Tax Rate, % -3.31 -3.31 -3.31 -3.31 -3.31 -3.31 -3.31 -3.31 -3.31 -3.31
EBITAT -22.5 -38.3 214.5 95.9 -157.0 3.7 2.6 1.8 1.3 .9
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -26.7 -31.0 214.1 97.9 -159.5 -.7 5.7 4.0 2.8 2.0
WACC, % 10.86 10.86 10.85 10.83 10.86 10.85 10.85 10.85 10.85 10.85
PV UFCF
SUM PV UFCF 10.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 2
Terminal Value 23
Present Terminal Value 14
Enterprise Value 24
Net Debt -245
Equity Value 269
Diluted Shares Outstanding, MM 36
Equity Value Per Share 7.52

What You Will Get

  • Real ITOS Financial Data: Pre-filled with iTeos Therapeutics' historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See iTeos Therapeutics' intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive Data: iTeos Therapeutics’ historical financial records and pre-filled projections.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Insights: View iTeos Therapeutics’ intrinsic value recalculating instantly.
  • Intuitive Visualizations: Dashboard graphs illustrate valuation outcomes and essential metrics.
  • Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.

How It Works

  • Download: Obtain the pre-prepared Excel file featuring iTeos Therapeutics, Inc.'s (ITOS) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare the results.
  • Make Decisions: Utilize the valuation outcomes to inform your investment strategy.

Why Choose This Calculator for iTeos Therapeutics, Inc. (ITOS)?

  • Comprehensive Tool: Features DCF, WACC, and financial ratio analyses tailored for biopharmaceuticals.
  • Customizable Inputs: Modify yellow-highlighted cells to explore different investment scenarios.
  • Detailed Insights: Automatically computes iTeos Therapeutics’ intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide a solid foundation for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and biotech consultants.

Who Should Use iTeos Therapeutics, Inc. (ITOS)?

  • Investors: Gain insights into innovative therapeutic solutions for informed investment choices.
  • Healthcare Analysts: Utilize comprehensive data to evaluate the potential of cutting-edge biopharmaceuticals.
  • Consultants: Tailor presentations and reports with up-to-date information on iTeos' product pipeline.
  • Biotech Enthusiasts: Explore the latest advancements in immunotherapy and cancer treatment through real-world applications.
  • Educators and Students: Leverage case studies and research from iTeos as a resource in life sciences education.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled iTeos Therapeutics historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for iTeos Therapeutics, Inc. (ITOS).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.